Margarida Maia - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Margarida Maia's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Margarida Maia
Verified
Science Writer, Multiple Sclerosis News Today
Lisbon
Beats
–
anything non-energy related
Content
By Margarida Maia Verified| SMA News Today Verified Testing patient DNA with advanced methods like HapSMA — which can “[analyze] … SMN and its surrounding genes” — can reveal otherwise undetectable genetic changes, such as gene conversion, that affect how severe spinal muscular atrophy (SMA) is, according to a study by researchers in the Netherlands. These novel methods may ultimately help in improving treatment for patients, the team noted.
By Margarida Maia Verified| Parkinson's News Today Verified Nearly 1 in 8 people diagnosed with Parkinson’s disease in Finland within the past couple of decades were later given a different diagnosis, usually within two years, underscoring the need for better clinical criteria and regular checkups. When Parkinson’s and dementia with Lewy bodies, a neurodegenerative disease also marked by a buildup of toxic clumps of misfolded alpha-synuclein protein, were treated as separate diagnoses, the rates of misdiagnoses increased further.
By Margarida Maia Verified| SMA News Today Verified Testing patient DNA with advanced methods like HapSMA — which can “[analyze] … SMN and its surrounding genes” — can reveal otherwise undetectable genetic changes, such as gene conversion, that affect how severe spinal muscular atrophy (SMA) is, according to a study by researchers in the Netherlands. These novel methods may ultimately help in improving treatment for patients, the team noted.
Company Info
Multiple Sclerosis News Today
Multiple Sclerosis News Today is a company based out of PHILADELPHIA, PA, United States.
'+1 800-936-1363